Neurogene Stock (NGNE)
Track Neurogene stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
NGNE
Neurogene
healthcare
$27.41
▲ +9.78 (+57.23%) past year
Market Cap
$428.23M
P/E Ratio
—
1Y Return
+57.23%
EPS (TTM)
-$5.02
Read the latest TheStreet Pro articles mentioning Neurogene, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning NGNE yet.
Daily Diary Mentions
0 mentionsNo diary mentions for NGNE yet.